High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma

Blockade of the programmed cell death 1-programmed cell death ligand 1 pathway is a new and promising therapeutic approach in Hodgkin lymphoma (HL). To our knowledge, the impact of soluble programmed cell death ligand 1 (sPD-L1) serum levels on HL patient prognosis has not yet been investigated. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaofang, Wang, Juan, Jin, Jietian, Chen, Hao, Zhen, Zijun, Jiang, Wenqi, Lin, Tongyu, Huang, Huiqiang, Xia, Zhongjun, Sun, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058012/
https://www.ncbi.nlm.nih.gov/pubmed/29698935
http://dx.doi.org/10.1016/j.tranon.2018.03.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058012/
https://www.ncbi.nlm.nih.gov/pubmed/29698935
http://dx.doi.org/10.1016/j.tranon.2018.03.012

Ejemplares similares